NIVEL, Netherlands Institute for Health Services Research, Utrecht, The Netherlands.
BMJ Open. 2013 Jul 24;3(7). doi: 10.1136/bmjopen-2013-003044. Print 2013.
Determine the adherence to recommendations of concomitant proton-pump inhibitor (PPI) treatment in regular low-dose of aspirin (LDASA) users, taking factors associated with the probability of receiving a PPI into account.
Cohort study.
Data were obtained from 120 Dutch primary care centres participating in the Netherlands Information Network of Primary Care (LINH).
Patients 18 years and older who were regularly prescribed LDASA (30-325 mg) in 2008-2010 were included.
Regular medication use was defined as receiving each consecutive prescription within 6 months after the previous one. Based on national guidelines, we categorised LDASA users into low and high gastrointestinal (GI) risk. A multilevel multivariable logistic regression analysis was applied to identify patient characteristics that influenced on the probability of regular PPI prescriptions.
We identified 12 343 patients who started LDASA treatment, of whom 3213 (26%) were at increased risk of GI complications. In this group, concomitant regular use of PPI was 46%, 36% did not receive PPI prescriptions and 18% obtained prescriptions irregularly (p<0.0001). The chance to obtain regularly PPI prescriptions versus no PPI was significantly influenced by, among others, previous GI complications (OR 13.9 (95% CI 11.8 to 16.4)), use of non-steroidal anti-inflammatory drugs (OR 5.2 (4.3 to 6.3)), glucocorticosteroids (6.1 (4.6 to 8.0)), selective serotonin reuptake inhibitors (9.1 (6.7 to 12.2)), drugs for functional GI disorders (2.4 (1.9 to 3.0)) and increased age.
Primary care physicians do not fully adhere to the current recommendations to prescribe PPIs regularly to LDASA users with an increased GI risk. More than 50% of the patients with an increased GI risk are not treated sufficiently with a concomitant PPI, increasing the risk of GI side effects. This finding underlines the necessity to consider merging recommendations into one common, standard and frequently used recommendation by primary care physicians.
确定在常规低剂量阿司匹林(LDASA)使用者中,同时使用质子泵抑制剂(PPI)治疗的依从性,同时考虑与接受 PPI 治疗概率相关的因素。
队列研究。
数据来自于 2008-2010 年参与荷兰初级保健信息网络(LINH)的 120 个荷兰初级保健中心。
纳入 18 岁及以上,在 2008-2010 年期间定期接受 LDASA(30-325mg)处方的患者。
常规用药定义为在之前的处方后 6 个月内连续接受每次处方。根据国家指南,我们将 LDASA 使用者分为低和高胃肠道(GI)风险两类。采用多水平多变量逻辑回归分析来确定影响 PPI 处方常规开具概率的患者特征。
我们确定了 12343 名开始 LDASA 治疗的患者,其中 3213 名(26%)存在胃肠道并发症风险增加。在这一组中,同时定期使用 PPI 的比例为 46%,36%未开具 PPI 处方,18%开具的处方不规律(p<0.0001)。与未开具 PPI 处方相比,获得定期 PPI 处方的机会显著受到以下因素的影响:既往胃肠道并发症(OR 13.9(95%CI 11.8 至 16.4))、使用非甾体抗炎药(OR 5.2(4.3 至 6.3))、糖皮质激素(OR 6.1(4.6 至 8.0))、选择性 5-羟色胺再摄取抑制剂(OR 9.1(6.7 至 12.2))、功能性胃肠道疾病药物(OR 2.4(1.9 至 3.0))和年龄增加。
初级保健医生没有完全遵循当前的建议,即对于胃肠道风险增加的 LDASA 使用者,定期开具 PPI 处方。超过 50%的胃肠道风险增加的患者未得到充分的 PPI 治疗,增加了胃肠道副作用的风险。这一发现强调了将建议合并为初级保健医生共同、标准和常用的建议的必要性。